Search Results
- < Prev
1 of 1
- Next >
News Releases
-
Jun 14, 2013, 08:00 ET
BELVIQ® (lorcaserin HCl) CIV Data to be Presented at ENDO 2013
Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), announced today that data from the BELVIQ® (lorcaserin HCl) Phase 3 clinical trial program will be presented at the following scientific meeting: ENDO 2013, the Endocrine Society's 95th Annual Meeting & Expo San Francisco:...
More news about: Arena Pharmaceuticals, Inc. , ENDO 2013, the Endocrine Society's 95th Annual Meeting & Expo , Eisai Inc.
-
Jun 14, 2013, 07:30 ET
Arena Pharmaceuticals to Present at the 2013 Wells Fargo Securities Healthcare Conference
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present a corporate overview at the 2013 Wells Fargo Securities Healthcare Conference on Wednesday, June 19, 2013, at 2:25 p.m. Eastern Time (11:25 a.m. Pacific Time), at the InterContinental...
More news about: Arena Pharmaceuticals, Inc.
- < Prev
1 of 1
- Next >
Modify your Search
| Quickly search for PR Newswire releases by adding our plugin to your browser search |
